What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022

AimsPersistent uncertainties exist surrounding the therapeutic drug monitoring (TDM) of adalimumab in clinical settings. To address these issues, we conducted a systematic review to assess the current evidence regarding the benefits of TDM for adalimumab.MethodsPubMed, EMBASE, and Cochrane Databases...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yun Li (Autor), Cheng Xie (Autor), Xiaoliang Ding (Autor), Ziyang Wu (Autor), Jingjing Zhang (Autor), Jianguo Zhu (Autor), Liyan Miao (Autor)
Format: Llibre
Publicat: Frontiers Media S.A., 2024-07-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible